The Effect of Experimental Cardiac Arrhythmias of a New Anticonvulsant Agent, Kö 1173, and Its Comparison with Phenytoin and Procainamide

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1970 May 1

PMID 4192640

Citations 6

Authors

J D Allen

J M Kofi

R G Shanks

S A Zaidi

Affiliations

Soon will be listed here.

Citing Articles

The influence of urinary pH on the elimination of mexiletine.

Kiddie M, Kaye C, Turner P, Shaw T Br J Clin Pharmacol. 2012; 1(3):229-32.

PMID: 22454952 PMC: 1402565. DOI: 10.1111/j.1365-2125.1974.tb00241.x.

The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.

Allen J, Ekue J, Shanks R, Zaidi S Br J Pharmacol. 1972; 45(4):561-73.

PMID: 5085230 PMC: 1665959. DOI: 10.1111/j.1476-5381.1972.tb08114.x.

Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173.

Singh B, VAUGHAN WILLIAMS E Br J Pharmacol. 1972; 44(1):1-9.

PMID: 5015038 PMC: 1665694. DOI: 10.1111/j.1476-5381.1972.tb07232.x.

Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent.

Clark R, Julian D, Nimmo J, Prescott L, Talbot R Br J Pharmacol. 1973; 47(3):622P-623P.

PMID: 4730842 PMC: 1776357.

Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.

Arita M, Goto M, Nagamoto Y, Saikawa T Br J Pharmacol. 1979; 67(1):143-52.

PMID: 497518 PMC: 2043595.

References

BIGGER Jr J, BASSETT A, Hoffman B . Electrophysiological effects of diphenylhydantoin on canine purkinje fibers. Circ Res. 1968; 22(2):221-36. DOI: 10.1161/01.res.22.2.221. View

Bernstein H, Gold H, LANG T, PAPPELBAUM S, BAZIKA V, CORDAY E . SODIUM DIPHENYLHYDANTOIN IN THE TREATMENT OF RECURRENT CARDIAC ARRHYTHMIAS. JAMA. 1965; 191:695-7. DOI: 10.1001/jama.1965.03080090009002. View